February 19 , 1789Kelso, Scotland August 18 , 1874Moor Park, England Sir William Fairbairn, 1st Baronet, (born February 19 , 1789 Kelso, Roxburghshire [now in Scottish Borders], Scotland died August 18 , 1874 Moor Park, Surrey, England) Scottish civil engineer and inventor who did pioneering work in bridge design and in testing iron and finding new applications for it.
Some of the studies tested iron alone and others iron in combination with folic acid, which is routinely used to reduce the risk for birth defects.
Of the tested iron chelators, ROS production by innate immune cells was most inhibited by yersiniabactin.
Of the tested iron chelators, yersiniabactin was the most effective in reducing the ROS production in the tested innate immune cells.
Importantly, no cytotoxicity was observed for any of the tested iron chelators (90 µM) against PMNs, PBMCs, or J774A.1 cells (data not shown).
Higher concentrations of deferiprone were also tested because deferiprone binds iron at a ratio of 1 iron to 3 deferiprone molecules, while the other tested iron chelators bind iron at 1∶1 ratio; however, the reduction of ROS production by 270 µM deferiprone was still less than the reduction following treatment with 90 µM yersiniabactin.
While it is controversial if the Haber-Weiss reaction takes place under physiological conditions, the fact that all tested iron chelators reduce, at least to some extent, ROS production in activated innate immune cells supports the hypothesis that this reaction can take place under physiological conditions.
Whilst liver function tests, iron and inflammatory markers were all normal, the patient complained of lethargy and nausea.
In order to test iron dependence for transcription we analyzed the expression of these genes under iron limited conditions (SA medium) and iron sufficient conditions (SA medium supplemented with FeCl3).
The qRT-PCR analysis confirmed these results and demonstrated that the expression of the tvactn3 gene is greatly reduced in the absence of iron in comparison to tvactn2 and tvactn1 expression, and tvactn4 and tvactn5 were not amplified under any of the tested iron concentrations and used experimental conditions.
These, together with the exclusion of alarm symptoms (such as rapid weight loss, hematochezia, family history of colorectal cancer or inflammatory bowel disease, positive faecal occult blood test, iron deficiency anaemia and a recent onset constipation) may lead to the diagnosis of functional constipation, often avoiding unnecessary and costly examinations.
